Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the closure of its second tranche, bringing the total of Series B to $51M. Investor Growth Capital (IGC) joined this tranche,…
Category: Business
LensAR Focuses On $2M of $7M Offering for Laser 3D Imaging Tech
Orlando-based LensAR has raised $2 million of a targeted $7 million offering, according to a regulatory filing. The company is developing and commercializing laser and 3D imaging technology for refractive cataract surgery. The company raised $7 million in equity in…
EyeMed Vision Care Expands Member Wellness Focus with Diabetic Eye Care Benefit
MASON, Ohio–(BUSINESS WIRE)–EyeMed Vision Care introduces a new Diabetic Eye Care benefit that provides follow-up care and supplementary diagnostic testing for patients with diabetes, a leading cause of adult blindness.
Neurotech’s NT-501 Implant Slows Vision Loss in Patients with Geographic Atrophy Associated with Dry AMD as Reported in PNAS
LINCOLN, R.I.–(BUSINESS WIRE)–Neurotech announced that it was reported in PNAS that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy associated with dry AMD in a Phase 2 study.
Alcon Posts Solid Fourth Quarter Financial Results
HUENENBERG, Switzerland–(BUSINESS WIRE)–Alcon, Inc. (NYSE:ACL) reported that global sales rose 5.7 percent to $1.81 billion for the fourth quarter of 2010. Revenue from acquisitions added 100 basis points to sales growth in the quarter, while foreign…
Research and Markets: Ophthalmic Devices Market Outlook in Japan to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/885688/ophthalmic_devices) has announced the addition of GlobalData’s new report “Ophthalmic Devices Market Outlook in Japan to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering. Ophthalmic Devices Market Outlook in Japan…
Research and Markets: Ophthalmic Devices Market Outlook in the United States (US) to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/e86f8c/ophthalmic_devices) has announced the addition of GlobalData ‘s new report “Ophthalmic Devices Market Outlook in the United States (US) to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering.
Research and Markets: Ophthalmic Devices Market Outlook in India to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/fb0df2/ophthalmic_devices) has announced the addition of GlobalData’s new report “Ophthalmic Devices Market Outlook in India to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering. Ophthalmic Devices Market Outlook in India…
Company Profile for Acucela Inc.
–(BUSINESS WIRE)–Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwid…
Lpath Grants Pfizer Exclusive Option for Worldwide License for AMD Treatment iSONEP
Lpath, Inc. has entered into an agreement providing Pfizer with an exclusive option for a worldwide license to develop and commercialize iSONEP Lpath’s lead monoclonal antibody product candidate, which is being evaluated for the treatment of wet age-…
Research and Markets: Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/4f2453/cataract_surgery) has announced the addition of GlobalData’s new report “Cataract Surgery – Global Pipeline Analysis, Opportunity Assessment and Market For…
Alcon and Novartis Agree to Merger Terms
HUENENBERG, Switzerland–(BUSINESS WIRE)–Alcon, Inc. (NYSE: ACL) announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not…
InSite Vision Names Timothy Ruane Chief Executive Officer
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has appointed Timothy Ruane as Chief Executive Officer (CEO) and elected Mr. Ruane to its Board of Directors, effective Decem…
Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook Report Available
Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. Our report, Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook provid…
Company Profile for Iris Pharma
–(BUSINESS WIRE)–Iris Pharma is an independent Contract Research Organization (CRO), dedicated to preclinical and clinical research in ophthalmology.
Research and Markets: Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. The report provides key data, information and analysis on the global premium IOLs market.
OptiMedica’s Catalys™ Precision Laser System Study Published in Science Translational Medicine Shows Marked Advancement in Cataract Surgery
SANTA CLARA, Calif.–(BUSINESS WIRE)–OptiMedica’s Catalys Precision Laser System study featured in the peer-reviewed journal Science Translational Medicine. Results show dramatic improvement in the precision of cataract surgery.
Iris Pharma, Winner of the High Performance Prize in the Growth Category
NICE, France–(BUSINESS WIRE)–IRIS PHARMA, WINNER OF THE HIGH PERFORMANCE PRIZE IN THE GROWTH CATEGORY.
Novartis could stick with 77 percent stake in Alcon
Swiss drugmaker Novartis AG has not ruled out sticking with its 77 percent stake in US-listed eyecare group Alcon, Novartis chief executive Joe Jimenez was quoted as saying on Tuesday. “The intention is to have 100 per cent. But Nestle owned 77 per c…
pSivida Corp. to Present at the Maxim Group Growth Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida to present at Maxim Group Growth Conference